HHS Stock Analysis: Buy, Sell, or Hold?
$2.51
-0.09 (-3.46%)
▼
5d:
-4.92%
30d:
-10.04%
90d:
-11.93%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: HHS shows positive signals but monitor for confirmation. Market pricing in 4.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: HHS shows positive signals but monitor for confirmation. Market pricing in 4.2% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.05
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.51
0.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $2.51, which is considered oversold relative to its 30-day fair value range of $2.60 to $2.81. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.4) compared to its historical average (2.7). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+597.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HHS is in a downtrend. The price is currently testing key support at $2.50. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+597.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.60 -
$2.81
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.5%)
- BULLISH: Trading 597.2% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.60 -
$2.81
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.50
Resistance Level
$2.70
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.35
Wall Street Target
$17.50
(+597.2%)
Revenue Growth (YoY)
-10.3%
Earnings Growth (YoY)
-90.3%
Profit Margin
-0.7%
Valuation Discount vs History
-4.2% cheaper
PE vs Historical
2.4 vs 2.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.2%
(market-implied from PE analysis)
1-Year Target
$2.40
(-4%)
2-Year Target
$2.30
(-8%)
3-Year Target
$2.21
(-12%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$2.54
(+1%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.3 to 2.7
Stabilization Target:
$2.89
(+15.1%)
PE Expansion Potential:
+15.1%
Share & Embed Analysis
Last updated: June 03, 2026 6:21 PM ET
Data refreshes hourly during market hours. Next update: 7:21 PM
Data refreshes hourly during market hours. Next update: 7:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HON
Honeywell International … |
BUY
26 analysts |
$248 | 61 BUY |
|
MMM
3M Company |
BUY
19 analysts |
$173 | 62 BUY |
|
BBU
Brookfield Business Part… |
STRONG BUY
6 analysts |
$41 | 58 HOLD |
|
VMI
Valmont Industries Inc |
STRONG BUY
5 analysts |
$527 | 63 BUY |
|
PAM
Pampa Energia SA ADR |
BUY
8 analysts |
$115 | 59 HOLD |